At M&A Healthcare Advisors, we closely monitor regulatory changes that influence transaction strategy and valuation in the healthcare sector. In
Press
Press
At M&A Healthcare Advisors, we closely monitor regulatory changes that influence transaction strategy and valuation in the healthcare sector. In
Overview: 2025 Healthcare M&A Mid-Market Expectations The 2025 healthcare M&A market is poised for transformation, driven by regulatory shifts under
Table Of Contents Technology Is Reshaping Behavioral Health M&A Telehealth Expands Access and Sustains Care Autism M&A on the Rise
Table Of Contents What Is Working Capital? Why Does Working Capital Matter in a Sale? How We Approach Working Capital
2024: The Good, the Bad, and the Uncertainty 2024 was characterized by a significant level of uncertainty. While the companies
M&A Healthcare Advisors: Looking Ahead to 2024 12 Active Sellside engagements currently in process 5 transactions are under LOI. 3
M&A Healthcare Advisors 2023 End of Year Review A slower than average 2023 deal cycle for Private Equity Buyers. Strongest
5 Successful Transactions 2 Transactions Facilitated Through M&A Consultation Services 4/5 Companies Represented Were Acquired by Strategic Organizations Valuations and
Video: 3 Key Takeaways from the Healthcare Transactions Conference In this video, Mark Thomas, Co-Founder and Director of Operations at
The Co-Founders of M&A Healthcare Advisors, Mark Thomas, Andre Ulloa, and Mike Moran, discuss their reflections and insights from 2022